Novo Nordisk's Diabetes Drug Outshines Ozempic: Buy?
A new diabetes drug from Novo Nordisk could change the GLP-1 landscape. This deep dive breaks down what investors sho...
Find out which ETFs consistently pay qualified dividends and how this impacts your tax strategy and after-tax returns.
22,163 articlesA new diabetes drug from Novo Nordisk could change the GLP-1 landscape. This deep dive breaks down what investors sho...
Active fund moves can shake even steady income plays. This article breaks down why cushing asset management sells Hes...
As incomes rise and borrowing costs ease, american homebuyers gain most purchasing power this year. The latest analys...
A retail-tech veteran leads Elevance Health’s push to modernize consumer experience and cost clarity in health benefi...
A high-stakes clash between Anthropic and the Pentagon nears a Friday deadline, drawing attention from markets and pe...
A new recession indicator signals Americans are financially tighter than forecasts suggested. This article breaks dow...
Oil prices jumped as traders priced a roughly four-week disruption to supply. Goldman Sachs analysts say the move ref...
A casual taste-test clip by McDonald’s CEO ignited a social-media firestorm. The incident quickly evolved into a broa...
Strategy Inc. escalated its Bitcoin purchases with a $1.3 billion bet funded largely by new common shares and STRC pr...
AI agents are increasingly handling payments in real time, but the security question remains: is crypto needed protec...
As lawmakers weigh incentives, chicago bears could actually relocate from Soldier Field. The move would reshape budge...
Team (TISI) kicks off 2025 with a solid Q1 showing that blends growing customer demand with margin challenges. This a...